Ocular Therapeutix (NASDAQ:OCUL – Free Report) and Innoviva (NASDAQ:INVA – Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Risk & Volatility Ocular Therapeutix has a beta of 1.22, […]